Valery A. Petrenko

Prof. Valery A. Petrenko

Auburn University
orcid

Research Focus & Metrics

Academic Career Length

20Years (2007-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
19 August 2008 in Expert Opinion on Drug Delivery
Verified
Journal Article
Closed access
Valery A. PetrenkoValery A. Petrenko
Valery A. Petrenko
Background: New phage-derived biorecognition nanomaterials have emerged recently as a result of the in-depth study of the genetics and structure of filamentous phage and the evolution of phage display technology. Objective: This review focuses on the progress made in the development of these new nanomaterials and discusses the prospects of using phage as a bioselectable molecular recognition interface in medical and technical devices. Methods: The author used data obtained both in his research group and sourced using Science Citation Index (Web of Science) search resources. Results/conclusion: The merging of phage display technologies with nanotechnology over the past few years has proved promising and has already shown its vitality and productivity by contributing vigorously to different areas of medicine and technology, such as medical diagnostics and monitoring, molecular imaging, targeted drug and gene delivery, vaccine development, as well as bone and tissue repair.

1 June 2011 in Nanomedicine: Nanotechnology, Biology and Medicine
Verified
Journal Article
Closed access
DBDeepa Bedi
Deepa Bedi
TMTiziana Musacchio
Tiziana Musacchio
OFOlusegun A. Fagbohun
Olusegun A. Fagbohun
JGJames Gillespie
James Gillespie
PDPatricia Deinnocentes
Patricia Deinnocentes
Valery A. PetrenkoValery A. Petrenko
Valery A. Petrenko

24 January 2018 in Nanoscale
Verified
Journal Article
Closed access
PDF file
PLPei Liu
Pei Liu
LHLei Han
Lei Han
FWFei Wang
Fei Wang
XLXiangqian Li
Xiangqian Li
Valery A. PetrenkoValery A. Petrenko
Valery A. Petrenko
ALAihua Liu
Aihua Liu
Colorimetric immunoassay for V. parahaemolyticus using screened phage pVIII fusion as capture probe coupled with MnO 2 nanosheets as signal probe.

28 October 2014 in Scientific Reports
Verified
Journal Article
Open access
FWFei Wang
Fei Wang
PLPei Liu
Pei Liu
LSLin Sun
Lin Sun
CLCuncheng Li
Cuncheng Li
Valery A. PetrenkoValery A. Petrenko
Valery A. Petrenko
ALAihua Liu
Aihua Liu
Nanomaterials with near-infrared (NIR) absorption have been widely studied in cancer detection and photothermal therapy (PTT), while it remains a great challenge in targeting tumor efficiently with minimal side effects. Herein we report a novel multifunctional phage-mimetic nanostructure, which was prepared by layer-by-layer self-assembly of Au@Ag heterogenous nanorods (NRs) with rhodamine 6G, and specific pVIII fusion proteins. Au@Ag NRs, first being applied for PTT, exhibited excellent stability, cost-effectivity, biocompatibility and tunable NIR absorption. The fusion proteins were isolated from phage DDAGNRQP specifically selected from f8/8 landscape phage library against colorectal cancer cells in a high-throughput way. Considering the definite charge distribution and low molecular weight, phage fusion proteins were assembled on the negatively charged NR core by electrostatic interactions, exposing the N-terminus fused with DDAGNRQP peptide on the surface. The fluorescent images showed that assembled phage fusion proteins can direct the nanostructure into cancer cells. The nanostructure was more efficient than gold nanorods and silver nanotriangle-based photothermal agents and was capable of specifically ablating SW620 cells after 10 min illumination with an 808 nm laser in the light intensity of 4 W/cm2. The prepared nanostructure would become an ideal reagent for simutaneously targeted optical imaging and PTT of tumor.

7 June 2018 in Viruses
Verified
Journal Article
Open access
PDF file
Valery A. PetrenkoValery A. Petrenko
Valery A. Petrenko
The development of phage engineering technology has led to the construction of a novel type of phage display library—a collection of nanofiber materials with diverse molecular landscapes accommodated on the surface of phage particles. These new nanomaterials, called the “landscape phage”, serve as a huge resource of diagnostic/detection probes and versatile construction materials for the preparation of phage-functionalized biosensors and phage-targeted nanomedicines. Landscape-phage-derived probes interact with biological threat agents and generate detectable signals as a part of robust and inexpensive molecular recognition interfaces introduced in mobile detection devices. The use of landscape-phage-based interfaces may greatly improve the sensitivity, selectivity, robustness, and longevity of these devices. In another area of bioengineering, landscape-phage technology has facilitated the development and testing of targeted nanomedicines. The development of high-throughput phage selection methods resulted in the discovery of a variety of cancer cell-associated phages and phage proteins demonstrating natural proficiency to self-assemble into various drug- and gene-targeting nanovehicles. The application of this new “phage-programmed-nanomedicines” concept led to the development of a number of cancer cell-targeting nanomedicine platforms, which demonstrated anticancer efficacy in both in vitro and in vivo experiments. This review was prepared to attract the attention of chemical scientists and bioengineers seeking to develop functionalized nanomaterials and use them in different areas of bioscience, medicine, and engineering.

8 January 2013 in Molecular Pharmaceutics
Verified
Journal Article
Closed access
DBDeepa Bedi
Deepa Bedi
JGJames Gillespie
James Gillespie
Andreas EbnerAndreas Ebner
Andreas Ebner
MLMichael Leitner
Michael Leitner
PHPeter Hinterdorfer
Peter Hinterdorfer
Valery A. PetrenkoValery A. Petrenko
Valery A. Petrenko